Clinical Trial Update: A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating intravenous livmoniplimab in combination with budigalimab in adults with locally advanced or metastatic hepatocellular carcinoma; the u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Livmoniplimab
• budigalimab (budigalimab)

Snippet

Sponsor: AbbVie | Conditions: Hepatocellular Carcinoma (HCC) | Phase 1 | Status: RECRUITING